A Requiem for Beta-Blockers to Treat Hypertension?
July 03, 2013

At the ASH meeting, one could get a pretty good sense of where the beta-blocker hypertension debate is headed.

Making the Most of Antihypertensive Drug Combinations
June 10, 2013

The number of people who require 2 or more antihypertensives to reach target blood pressure is on the increase. So, simply stated, what goes best with what? The 2013 ASH meeting offered some good suggestions under the heading of “Within Class Differences.”

ASH 2013: Post Script
May 22, 2013

Lowering blood pressure saves lives and primary care practice is where treatment for hypertension begins.

Reflections on ASH 2013: Lessons in Quality Improvement
May 22, 2013

Resistant hypertension requires aggressive treatment with multiple drugs. Spironolactone is a key addition to the regimen.

Treating Hypertension in the Hospital: A Few Scenarios That Challenge Primary Care
May 22, 2013

Hypertension in hospitalized patients is best treated conservatively.

A Future of Beta-Blockers “Plus” to Treat Hypertension?
May 21, 2013

More about the current move away from beta-blocker therapy for hypertension as discussed by speakers at the 2013 ASH annual meeting. Following are some more of the key points, including a discussion of so-called beta-blockers "plus."

Filling Gaps in Hypertension Rx: Sleep Disorders and Stroke
May 16, 2013

ASH 2013 has uncovered 2 glaring gaps in the management of people with sleep disorders (OSA as well as others) and appropriate care after a stroke. Both cohorts frequent primary care practice.

Some Do’s and Don’ts for Tough-to-Treat Hypertensives
May 16, 2013

Patients with resistant hypertension and hypertensive patients prone to hyperkalemia are on the rise. They are not easy to care for, but certain “tricks of the trade” can help. Details here.

Hypertension Meeting Has Primary Care Track
May 15, 2013

The meeting's goals are to increase understanding and, perhaps, find a cure.